ProCE Banner Activity

My Perspective on Current Challenges and Future Opportunities in Treating Immune Thrombocytopenia

Clinical Thought
Gain expert insights on some of the challenges and opportunities in the treatment of patients with immune thrombocytopenia in this commentary.

Released: October 08, 2021

Expiration: October 07, 2022

No longer available for credit.

Share

Faculty

Keith R. McCrae

Keith R. McCrae, MD

Professor, Medicine/Hematology/Oncology
Case Western Reserve University School of Medicine
Cleveland, Ohio

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Amgen, Inc.

Dova Pharmaceuticals

Sanofi Genzyme

Faculty Disclosure

Primary Author

Keith R. McCrae, MD

Professor, Medicine/Hematology/Oncology
Case Western Reserve University School of Medicine
Cleveland, Ohio

Keith R. McCrae, MD, has disclosed that he has received consulting fees from Dova, Novartis, Rigel, and Sanofi Genzyme.